Nova Mentis (OTC: NMLSF) Sees Rapid Enrollment in Autism Study
Databank to focus on mRNA neuroinflammatory markers and serotonin neuro-transmitters VANCOUVER, BC, April 28, 2022 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics […]